Chronic Endometritis After Failed Embryo Transfer: Tests, Treatment and Uncertainty

Chronic endometritis is not the same as the endometriosis that grows outside the uterus. It may be suspected from certain symptoms, examination or history, but many affected patients have no characteristic symptoms. A biopsy or hysteroscopic assessment may be discussed in selected cases. Ask which diagnostic criteria the laboratory will use and how reliable they are.

Staining for plasma cells, including CD138, is one laboratory technique, but thresholds and interpretation can differ. A positive result should be considered alongside symptoms and history rather than treated as a universal cause of a prior failed transfer. A negative test does not explain every other possible reason for implantation failure either.

Potential contributors to unsuccessful transfer include embryo factors, uterine cavity findings and chance, along with protocol timing and relevant medical conditions. The priority is a balanced review rather than a sequence of unvalidated add-ons. Ask what the team has already checked and whether repeating a recent normal uterine assessment would offer new information.

Antibiotics may be prescribed when there is a clinically supported diagnosis, but routine or repeated empiric antibiotics have downsides, including adverse effects and antimicrobial resistance. Patients should ask whether treatment choice is evidence-based for their situation and how, if at all, response will be assessed. Do not self-medicate based on a pathology phrase alone.

A second opinion can help interpret a biopsy report, check the transfer record and discuss whether other investigations are more useful. If biopsy is proposed, clarify procedure discomfort, risks, cost and the implications of both positive and negative results. The test should have a clear clinical question, not merely satisfy a desire to do something after disappointment.

HomeIVF may coordinate document review and follow-up discussions by teleconsultation and selected peripheral tests where feasible. Uterine biopsy, hysteroscopy, necessary imaging, embryo culture and transfer remain facility-based. A doctor-led home-supported pathway can reduce administrative travel without making an invasive investigation a home procedure.

One failed transfer can be deeply upsetting, but it does not prove that the uterus rejected an embryo. A review of embryo development, transfer technique, lining preparation and the number of prior attempts should come before a broad add-on panel. If a clinician proposes tissue sampling, ask whether there are symptoms, risk factors or imaging findings that increase the relevance of chronic endometritis in this specific case.

Antibiotic treatment is sometimes described online as a simple solution. In practice, the decision depends on whether the suspected diagnosis is sound and how the centre interprets results. Discuss side effects, allergies, resistance and the uncertainty around repeat biopsies. A report that is hard to interpret should prompt a conversation with the treating doctor or pathologist, not automatically a second prescription. Avoid treating the pathology label as a complete explanation of fertility.

A home-supported fertility pathway can help with the coordination surrounding treatment rather than moving IVF itself out of the laboratory. HomeIVF describes doctor-led consultation and selected support services that may include home blood collection or injection assistance where available and clinically appropriate. Patients should ask who takes samples, where those samples are analysed and who makes the medical decision. Required scans and procedures such as retrieval, embryology and transfer cannot be done in the living room. A written escalation plan remains important when a result or symptom changes suddenly.

Consider writing down a short decision statement after the discussion: the current diagnosis or uncertainty, the proposed next step, its reason, the main alternative and when reassessment will occur. The document should include who is responsible for prescriptions and what to do when instructions conflict. Treatment should not be presented as a guarantee, and people should be free to ask for clarification before agreeing to another cycle. If a recommendation depends on a specialised laboratory technique, request its limitations as well as possible benefits.

• Why do you suspect chronic endometritis in my case?
• What diagnostic definition will the pathologist use?
• What would change if the test is positive or negative?

Do not wait for a routine remote appointment if there is severe or worsening pelvic pain, heavy bleeding, fainting, marked abdominal swelling, breathing difficulty or another acute concern. Some symptoms can require urgent assessment, including after fertility procedures or in early pregnancy. Follow the treating centre's emergency instructions or seek local emergency care. An online article cannot determine whether symptoms are harmless.

For the clinical question 'chronic endometritis after failed IVF', the treating team should be able to explain why a finding matters and what evidence supports the next action. Laboratory figures and procedural decisions can be affected by timing, patient history and the method used. A useful second opinion distinguishes what is established from what remains uncertain, and it compares clinically reasonable options rather than assuming one treatment must be repeated indefinitely. Ask for an explanation that uses your actual reports, not a success story or an advertisement. Every intervention requires informed consent and a discussion of its limitations.

The most useful next step is a documented, clinician-led discussion of the individual's reports and realistic options. HomeIVF can be considered for supportive care coordination where it is actually available, while medical indications and safety determine which appointments must remain onsite. Information here is educational and cannot replace an individual assessment.